VALENCIA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Q2 net revenue grew 18% year over year and 13% sequentially quarter-over-quarter to a record $21.7 million Revenue growth driven by continued execution across the Company's ke ...